3 articles
Opie joins ASX-listed Australian assistive-tech company Control Bionics as Non-Executive Director and strategic advisor, with 1.25 million options vesting over four years pending shareholder approval at the 2026 AGM.
Oman Investment Authority's Neuralink position is the latest entry in a sovereign-capital and tech-billionaire cohort racing into brain-computer interfaces.
Synchron ranked eighth on Fast Company's 2026 most innovative data science companies list, reflecting a strategic pivot from hardware maker to neural data platform.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. One-click unsubscribe. We respect your privacy.